The effect of exogenous surfactant in patients with lung contusions and acute lung injury
- PMID: 17377767
- DOI: 10.1007/s00134-007-0597-z
The effect of exogenous surfactant in patients with lung contusions and acute lung injury
Abstract
Objective: To investigate the acute effect of surfactant replacement in multiple-trauma patients with lung contusion and acute lung injury.
Design and setting: Prospective randomized clinical trial in the 14-bed ICU of a 750-bed university hospital.
Patients and participants: Sixteen ventilated trauma patients with severe refractory hypoxemia (PaO(2)/FIO(2)<150 mmHg) and lung contusions.
Interventions: Patients were randomly assigned to either surfactant administration (n=8) or standard treatment (n=8). A single dose of natural bovine surfactant was instilled bronchoscopically in the involved lung areas; each segmental bronchus received (200/19) mg/kg body weight.
Measurements and results: The surfactant group demonstrated an acute improvement in oxygenation after surfactant replacement compared both to control group and to baseline values. In the surfactant group PaO(2)/FIO(2) increased from 100+/-20 mmHg at baseline to 140+/-20 (6 h), 163+/-26 (12 h), and 187+/-30 mmHg (24h). Compliance increased from 30 to 36 ml/cmH(2)O at 6 h after administration, and this increase remained significant at the 24, 48, and 72 h time points. The surfactant group demonstrated a higher response to recruitment maneuvers than the control group at 6 h. The mean duration of ventilatory support was 5.6 +/-2.6 days in the surfactant group and 8.1+/-2.4 days in the control group.
Conclusions: Surfactant replacement was well tolerated in patients with lung contusions and severe hypoxemia and resulted in improved oxygenation and compliance.
Similar articles
-
Treatment with bovine surfactant in severe acute respiratory distress syndrome in children: a randomized multicenter study.Intensive Care Med. 2003 Mar;29(3):437-46. doi: 10.1007/s00134-003-1650-1. Epub 2003 Feb 15. Intensive Care Med. 2003. PMID: 12589529 Free PMC article. Clinical Trial.
-
Impact of positive end-expiratory pressure on the definition of acute respiratory distress syndrome.Intensive Care Med. 2003 Nov;29(11):1936-42. doi: 10.1007/s00134-003-1943-4. Epub 2003 Sep 4. Intensive Care Med. 2003. PMID: 12955187
-
"Ideal PEEP" is superior to high dose partial liquid ventilation with low PEEP in experimental acute lung injury.Intensive Care Med. 2001 Dec;27(12):1937-48. doi: 10.1007/s00134-001-1142-0. Epub 2001 Nov 10. Intensive Care Med. 2001. PMID: 11797031
-
Independent lung ventilation in patients with unilateral pulmonary contusion. Monitoring with compliance and EtCO(2).Intensive Care Med. 2001 Dec;27(12):1860-7. doi: 10.1007/s00134-001-1149-6. Epub 2001 Nov 8. Intensive Care Med. 2001. PMID: 11797020 Clinical Trial.
-
Severe hypoxemia: which strategy to choose.Crit Care. 2016 Jun 3;20(1):132. doi: 10.1186/s13054-016-1304-7. Crit Care. 2016. PMID: 27255913 Free PMC article. Review.
Cited by
-
Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials.BMC Pulm Med. 2019 Jan 9;19(1):9. doi: 10.1186/s12890-018-0761-y. BMC Pulm Med. 2019. PMID: 30626363 Free PMC article.
-
Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions.Diagnostics (Basel). 2023 Sep 15;13(18):2964. doi: 10.3390/diagnostics13182964. Diagnostics (Basel). 2023. PMID: 37761330 Free PMC article. Review.
-
The clinical practice guideline for the management of ARDS in Japan.J Intensive Care. 2017 Jul 25;5:50. doi: 10.1186/s40560-017-0222-3. eCollection 2017. J Intensive Care. 2017. PMID: 28770093 Free PMC article.
-
Impact of differences in acute respiratory distress syndrome randomised controlled trial inclusion and exclusion criteria: systematic review and meta-analysis.Br J Anaesth. 2021 Jul;127(1):85-101. doi: 10.1016/j.bja.2021.02.027. Epub 2021 Apr 1. Br J Anaesth. 2021. PMID: 33812666 Free PMC article.
-
Veno-venous ECMO as a platform to evaluate lung lavage and surfactant replacement therapy in an animal model of severe ARDS.Intensive Care Med Exp. 2020 Oct 27;8(1):63. doi: 10.1186/s40635-020-00352-w. Intensive Care Med Exp. 2020. PMID: 33108583 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources